Corcept Therapeutics Inc (CORT)
22.21
-0.27
(-1.20%)
USD |
NASDAQ |
Apr 25, 16:00
22.50
+0.29
(+1.31%)
After-Hours: 20:00
Corcept Therapeutics Total Liabilities (Quarterly): 114.81M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 114.81M |
| September 30, 2023 | 132.34M |
| June 30, 2023 | 103.01M |
| March 31, 2023 | 88.26M |
| December 31, 2022 | 81.59M |
| September 30, 2022 | 59.89M |
| June 30, 2022 | 54.04M |
| March 31, 2022 | 60.31M |
| December 31, 2021 | 47.95M |
| September 30, 2021 | 45.17M |
| June 30, 2021 | 45.80M |
| March 31, 2021 | 41.60M |
| December 31, 2020 | 48.39M |
| September 30, 2020 | 44.44M |
| June 30, 2020 | 44.12M |
| March 31, 2020 | 36.00M |
| December 31, 2019 | 41.13M |
| September 30, 2019 | 32.65M |
| June 30, 2019 | 30.63M |
| March 31, 2019 | 34.46M |
| December 31, 2018 | 35.81M |
| September 30, 2018 | 40.21M |
| June 30, 2018 | 30.87M |
| March 31, 2018 | 27.75M |
| December 31, 2017 | 29.57M |
| Date | Value |
|---|---|
| September 30, 2017 | 24.37M |
| June 30, 2017 | 20.39M |
| March 31, 2017 | 25.76M |
| December 31, 2016 | 27.37M |
| September 30, 2016 | 31.68M |
| June 30, 2016 | 31.18M |
| March 31, 2016 | 32.74M |
| December 31, 2015 | 33.40M |
| September 30, 2015 | 34.90M |
| June 30, 2015 | 36.83M |
| March 31, 2015 | 37.65M |
| December 31, 2014 | 38.02M |
| September 30, 2014 | 38.48M |
| June 30, 2014 | 40.94M |
| March 31, 2014 | 43.46M |
| December 31, 2013 | 42.06M |
| September 30, 2013 | 40.28M |
| June 30, 2013 | 39.32M |
| March 31, 2013 | 37.14M |
| December 31, 2012 | 37.39M |
| September 30, 2012 | 33.87M |
| June 30, 2012 | 5.816M |
| March 31, 2012 | 3.57M |
| December 31, 2011 | 5.026M |
| September 30, 2011 | 2.713M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
30.63M
Minimum
Jun 2019
132.34M
Maximum
Sep 2023
60.64M
Average
47.95M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Ultragenyx Pharmaceutical Inc | 1.216B |
| Alnylam Pharmaceuticals Inc | 4.051B |
| Catalyst Pharmaceuticals Inc | 82.23M |
| United Therapeutics Corp | 1.182B |
| XOMA Corp | 145.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 621.52M |
| Shareholders Equity (Quarterly) | 506.70M |
| Current Ratio | 4.389 |